| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/16/2004 | CN1504483A NF-ª—B inhibitor, preparing process thereof and application as antineoplastic medicine |
| 06/16/2004 | CN1504482A Separation and purification process for acellular whooping cough antigen albumen |
| 06/16/2004 | CN1504481A Apoptosis promoting gene BNIPL, coding albumen and uses thereof |
| 06/16/2004 | CN1504476A Polynucleotide for identifying polypeptide OT3 and coding OT3 of tumor cell and uses thereof |
| 06/16/2004 | CN1504475A Polynucleotide for identifying polypeptide OT10 and coding OT10 of tumor cell and uses thereof |
| 06/16/2004 | CN1504240A Recombinated adeno-associated virus genes vaccine for prevention and cure of Alzheimer disease and use thereof |
| 06/16/2004 | CN1153854C Ferro-nickel alloy electroplating process for copper plate working surface of continuously casting crystallizer |
| 06/16/2004 | CN1153831C Gene of encoding endoglycoceramidase activator |
| 06/16/2004 | CN1153830C Modulators of anchoring protein function |
| 06/16/2004 | CN1153780C Protein with thrombopoiesis substance activity |
| 06/16/2004 | CN1153606C Chelate-forming filter, process for producing the same, and method of purifying liquid with the filter |
| 06/16/2004 | CN1153589C Treatment of infertility and enhancement of fertilization capacity in mammalian males |
| 06/15/2004 | US6750381 Pathogen-resistant plants transformed with a DNA encoding sarcotoxin 1A linked to a signal peptide and a method for production thereof |
| 06/15/2004 | US6750380 Producing stable dwarf crop plants |
| 06/15/2004 | US6750378 Maize H3C4 promoter combined with the first intron of rice actin, chimeric gene comprising it and transformed plant |
| 06/15/2004 | US6750375 Animal model for use in the treatment of eating disorders |
| 06/15/2004 | US6750334 Ctla4 (cd28-like which are t lymphocyte molec) used to suppress an immune response in the subject, for example to inhibit transplantation rejection, graft versus host disease or autoimmune response |
| 06/15/2004 | US6750330 Lyophilized tubulins |
| 06/15/2004 | US6750327 Compositions and method for determining the presence of human PTTG peptide in a sample |
| 06/15/2004 | US6750324 Agents and methods for treatment of diseases associated with amyloid deposits of a beta in the brain such as alzheimer's disease; entail administering agents that induce a beneficial immunogenic response against the amyloid deposit |
| 06/15/2004 | US6750323 Platelet activation protein |
| 06/15/2004 | US6750322 Guanosine triphosphate (GTP) binding protein-coupled receptor proteins |
| 06/15/2004 | US6750321 Insulin-like growth factor agonist molecules |
| 06/15/2004 | US6750312 Process for the preparation of supports for solid phase synthesis |
| 06/15/2004 | US6750206 Recombinant nucleic acid vector comprising a nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface |
| 06/15/2004 | US6750203 Inhibition of inductive effect of beta casein on insulin-dependent diabetes comprising administering to newborns and infants an infant formula free of beta caseins that exhibit molecular mimicry with protein glut2 |
| 06/15/2004 | US6750201 Peptide which promotes binding of scupa to lm-tk- cells and thereby promotes internalization and degradation of scupa by those cells |
| 06/15/2004 | US6750200 M2GlyR derived channel forming peptides |
| 06/15/2004 | US6750197 Activators of endothelial nitric oxide synthase |
| 06/15/2004 | US6750196 Methods of treating disorders of the eye |
| 06/15/2004 | US6750058 For treatment and prevention of human and animal diseases; in particular capable of dispensing to suitable target cells nucleic sequences, proteins, peptides and chemical substances via transfection |
| 06/15/2004 | US6750056 Metal binding proteins and associated methods |
| 06/15/2004 | US6750054 Nuclelotide sequences coding preferential polypeptide; for use in human therapeutics, diagnostics and pharmacology |
| 06/15/2004 | US6750052 Lens epithelial cell derived growth factor |
| 06/15/2004 | US6750047 Fermentation and purification of migrastatin and analog |
| 06/15/2004 | US6750046 Preparation of thioredoxin and thioredoxin reductase proteins on oil bodies |
| 06/15/2004 | US6750045 Fermentation medium and method |
| 06/15/2004 | US6750044 For producing pharmaceutically active materials having therapeutic and pharmacologic properties that differ from native vegf protein |
| 06/15/2004 | US6750042 Recombinant nucleotide sequences coding protein which binds mercury and cadium ions; concentrating and sequestering of heavy metal impurities in irrigation water, soils and gastrointestinal system of humans and animals |
| 06/15/2004 | US6750029 Methods and agents for the detection and modulation of cellular immunity to immune privileged antigens |
| 06/15/2004 | US6750026 To diagnose diseases relating to under- or over-expression of hfgan72 receptor ligands; for treatment of obesity, diabetes, anorexia nervosa, bulimia, cachexia, chronic renal failure, congestive heart failure |
| 06/15/2004 | US6750025 Method of detecting and isolating prion protein and variants thereof |
| 06/15/2004 | US6750012 For identifying compounds that do not induce motor side effects |
| 06/15/2004 | US6750008 Use of peptides for inhibition of human and non-human retroviral, especially hiv, transmission to uninfected cells |
| 06/15/2004 | US6749858 Nucleotide sequences coding polypeptide for use in the prevention of streptoccocus infection |
| 06/15/2004 | US6749857 Recombinant dimeric envelope vaccine against flaviviral infection |
| 06/15/2004 | US6749856 Mucosal cytotoxic T lymphocyte responses |
| 06/15/2004 | US6749855 Treating peripheral resistance in a mammal; modulating the immune response in a mammal |
| 06/15/2004 | US6749854 Use of OX-2 to inhibit fetal loss |
| 06/15/2004 | US6749847 Chemokine for use in of tumors |
| 06/15/2004 | US6748900 Methods for growing and imprinting fish using an odorant |
| 06/15/2004 | CA2285921C Composition and method for treatment of cmv infections |
| 06/15/2004 | CA2159330C Inhibition of leukocyte adhesion |
| 06/15/2004 | CA2049921C Allergenic proteins from ragweed and uses therefor |
| 06/10/2004 | WO2004048971A1 Methods of protecting against radiation damage using alpha thymosin |
| 06/10/2004 | WO2004048925A2 NaCT AS A TARGET FOR LIFESPAN EXPANSION AND WEIGHT REDUCTION |
| 06/10/2004 | WO2004048610A1 Methods of diagnosing and treating diabetes and obesity |
| 06/10/2004 | WO2004048608A1 Novel real-time rt-pcr for the sensitive detection of multiple mage gene transcripts |
| 06/10/2004 | WO2004048599A2 Transporters and ion channels |
| 06/10/2004 | WO2004048591A2 Methods for cohort selection and longevity studies |
| 06/10/2004 | WO2004048588A1 Process for purifying a fermentation-derived product |
| 06/10/2004 | WO2004048578A1 Soluble notch-based substrates for gamma secretase and methods and compositions for using same |
| 06/10/2004 | WO2004048575A2 Streptococcus pneumoniae surface polypeptides |
| 06/10/2004 | WO2004048574A1 Immunoreceptor proteins |
| 06/10/2004 | WO2004048573A1 Mammalian prickle gene |
| 06/10/2004 | WO2004048568A1 UTILIZATION OF mKank GENE IN CANTER THERAPY, CANER DETECTION AND DRUG DISCOVERY |
| 06/10/2004 | WO2004048567A2 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 06/10/2004 | WO2004048565A1 Apoptosis-associated protein and use thereof |
| 06/10/2004 | WO2004048550A2 Immune response associated proteins |
| 06/10/2004 | WO2004048549A2 Dep-1 receptor protein tyrosine phosphatase interacting proteins and related methods |
| 06/10/2004 | WO2004048547A2 Intermedin and its uses |
| 06/10/2004 | WO2004048537A2 Lamps as modifiers of the p53 pathway and methods of use |
| 06/10/2004 | WO2004048535A2 Sugar and lipid metabolism regulators in plants v |
| 06/10/2004 | WO2004048530A2 Compositions and methods for the reversible capture of biomolecules |
| 06/10/2004 | WO2004048529A2 Cell adhesion and extracellular matrix proteins |
| 06/10/2004 | WO2004048527A2 Cells resistant to chemotherapeutic compounds and uses thereof |
| 06/10/2004 | WO2004048521A2 Composition and method for treating lupus nephritis |
| 06/10/2004 | WO2004048520A2 Redd1, a transcriptional target of p63 and p53, and methods of use therefor |
| 06/10/2004 | WO2004048518A2 Organelle-associated proteins |
| 06/10/2004 | WO2004048516A2 Elf3 gene compositions and methods |
| 06/10/2004 | WO2004048515A2 Streptococcus uberis adhesion molecule |
| 06/10/2004 | WO2004048512A2 Novel proteins and nucleic acids encoding same |
| 06/10/2004 | WO2004048451A2 Optical information carrier comprising immobilized proteorhodopsin |
| 06/10/2004 | WO2004048411A2 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion |
| 06/10/2004 | WO2004048410A2 T-cell receptors |
| 06/10/2004 | WO2004048409A2 Mutants of the tumor necrosis factor alpha with deletion of n-terminal amino acids |
| 06/10/2004 | WO2004048408A2 Asb-a transcription repressor proteins and nucleic acids and their application in expansion of stem cells |
| 06/10/2004 | WO2004048407A1 Antimicrobial peptide isolated from halocynthia aurantium |
| 06/10/2004 | WO2004048406A1 Nucleic acid comprising a sequence encoding a modified glutenin polypeptide |
| 06/10/2004 | WO2004048405A1 Elastin substitute |
| 06/10/2004 | WO2004048403A2 Hepatisis c virus nonstructural protein 4a (ns4a) is an enhancer element |
| 06/10/2004 | WO2004048402A2 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 06/10/2004 | WO2004048401A1 Peptides and medicinal compositions containing the same |
| 06/10/2004 | WO2004047871A2 Modified naturetic compounds, conjugates, and uses thereof |
| 06/10/2004 | WO2004047867A1 Colon cancer metastasis inhibitor |
| 06/10/2004 | WO2004047863A2 Genetic products differentially expressed in tumors and the use thereof |
| 06/10/2004 | WO2004047861A1 Vaccines against viruses with cationic substances as adjuvants |
| 06/10/2004 | WO2004047859A2 Prekallikrein depleted plasma derived albumin fraction |
| 06/10/2004 | WO2004047856A1 Cancer metastasis inhibitor |
| 06/10/2004 | WO2004047855A2 Proteins involved in the regulation of energy homeostasis |